Online citations, reference lists, and bibliographies.
← Back to Search

New Formulation Of Vasoactive Intestinal Peptide Using Liposomes In Hyaluronic Acid Gel For Uveitis.

L. Lajavardi, Serge Camelo, F. Agnely, W. Luo, B. Goldenberg, M. Naud, F. Béhar-Cohen, Y. de Kozak, A. Bochot
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We evaluated the benefits of a novel formulation of vasoactive intestinal peptide (VIP) based on the incorporation of VIP-loaded rhodamine-conjugated liposomes (VIP-Rh-Lip) within hyaluronic acid (HA) gel (Gel-VIP-Rh-Lip) for the treatment of endotoxin-induced uveitis (EIU) in comparison with VIP-Rh-Lip alone. In vitro release study and rheological analysis showed that interactions between HA chains and liposomes resulted in increased viscosity and reinforced elasticity of the gel. In vivo a single intravitreal injection of Gel-VIP-Rh-Lip was performed in rats 7 days prior to uveitis induction by subcutaneous lipopolysaccharide injection. The maximal ocular inflammation occurs within 16-24 h in controls (VIP-Rh-Lip, unloaded-Rh-Lip). Whereas intraocular injection of VIP-Rh-Lip had no effect on EIU severity compared with controls, Gel-VIP-Rh-Lip reduced significantly the clinical score and number of inflammatory cells infiltrating the eye. The fate of liposomes, VIP and HA in the eyes, regional and inguinal lymph nodes and spleen was analyzed by immunostaining and fluorescence microscopy. Retention of liposomes by HA gel was observed in vitro and in vivo. Inflammation severity seemed to impact on system stability resulting in the delayed release of VIP. Thus, HA gel containing VIP-Rh-Lip is an efficient strategy to obtain a sustained delivery of VIP in ocular and lymph node tissues.
This paper references
10.1016/j.colsurfb.2006.12.005
Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
Spyridon D. Mourtas (2007)
10.1006/EXER.1997.0422
Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation.
J. Hollyfield (1998)
10.1023/A:1012062424662
Development of a Novel Bioactive Formulation of Vasoactive Intestinal Peptide in Sterically Stabilized Liposomes
F. Séjourné (2004)
Diagnosis and Treatment of Uveitis1 ed
C. S. Foster (2002)
Y
J. M. Ruiz-Moreno (1992)
10.1159/000267163
Retino-choroidal changes in endotoxin-induced uveitis in the rat.
J. Ruiz-Moreno (1992)
10.1023/A:1011989202488
Liposomes Dispersed Within a Thermosensitive Gel: A New Dosage Form for Ocular Delivery of Oligonucleotides
A. Bochot (2004)
10.1007/978-3-540-30798-3_13
Immunotherapy of Uveitis: is Gene Therapy in our Future?
R. Caspi (2007)
10.1159/000119866
Drainage of Fluorescent Liposomes from the Vitreous to Cervical Lymph Nodes via Conjunctival Lymphatics
S. Camelo (2008)
10.1089/jop.2008.0074
Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
Serge Camelo (2009)
Y
I. Pouvreau (1998)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/S1471-4906(03)00029-2
Hyaluronan--magic glue for the regulation of the immune response?
C. Termeer (2003)
10.3341/KJO.2004.18.1.23
Effects of hyaluronic acid on the polymorphonuclear leukocyte (PMN) release of active oxygen and protection of bovine corneal endothelial cells from activated PMNs.
Hyun Soo Lym (2004)
10.1080/09273940500545684
The Pros and Cons of Intravitreal Triamcinolone Injections for Uveitis and Inflammatory Cystoid Macular Edema
B. van Kooij (2006)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1111/j.1755-3768.1993.tb04637.x
Healon® GV in posterior segment surgery
S. Crafoord (1993)
Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis.
F. Valamanesh (2007)
10.1016/J.COLSURFB.2006.12.005
Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
S. Mourtas (2007)
10.1038/eye.1996.159
The biochemical structure of mammalian vitreous
P. Bishop (1996)
Girolamo,Neutrophil accumulation correlateswith type IV collagenase/gelatinase activity in endotoxin induced uveitis, Br
C. Cuello (2002)
10.1016/j.ejpb.2008.04.013
Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone.
Carolina Gómez-Gaete (2008)
10.1167/iovs.08-2935
Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
L. Heindl (2009)
10.1016/S1471-4906(02)02302-5
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
A. Mantovani (2002)
Phosphorus assay in column chromatography.
G. R. Bartlett (1959)
10.3109/02713689608995835
Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2.
D. Brown (1996)
Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats
S. Camelo (2007)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
The pros and cons of intravitreal triamcinolone injections for uveitis and in fl ammatory cystoid macular edema
A. Rothova B. Van Kooij (2006)
10.1345/aph.1H540
Retisert: Is the New Advance in Treatment of Uveitis a Good One?
Dina A Mohammad (2007)
10.1136/bjo.86.3.290
Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis
C. Cuello (2002)
10.1002/9780470513774.CH4
Turnover and metabolism of hyaluronan.
J. E. Fraser (1989)
Liggett,M.D. Trousdale, Sodiumhyaluronate as a carrier for intravitreal gentamicin
C. A. Moreira (1991)
10.1021/BI962332F
Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol-lecithin vesicles.
A. Luk (1997)
10.1016/J.COLSURFA.2004.06.030
Supramolecular structures prevailing in aqueous hyaluronic acid and phospholipid vesicles mixtures: an electron microscopy and rheometric study
V. Crescenzi (2004)
Y
S. Camelo (2007)
Hyaluronan
T. C. Laurent (1992)
10.1016/J.IT.2005.09.009
Hyaluronan cross-linking: a protective mechanism in inflammation?
A. J. Day (2005)
10.1016/J.OPHTHA.2006.02.021
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
G. Jaffe (2006)
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
10.1016/S0378-5173(02)00683-X
Influence of methyl-beta-cyclodextrin and liposomes on rheological properties of Carbopol 974P NF gels.
Laïla Boulmedarat (2003)
10.1111/j.1755-3768.1991.tb01989.x
Sodium hyaluronate as a carrier for intravitreal gentamicin an experimental study
C. A. Moreira (1991)
10.5040/9781474284028.0024
S
A. Kumar (1824)
P
B. Van Kooij (2006)
10.1016/S0165-5728(98)00042-3
Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis
I. Pouvreau (1998)
10.4049/jimmunol.172.9.5388
The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye1
Serge Camelo (2004)
10.1007/s11095-005-4591-2
Cyclodextrin-Mediated Drug Release from Liposomes Dispersed Within a Bioadhesive Gel
Laïla Boulmedarat (2005)
10.1177/002215549904701013
Intracellular Localization of Hyaluronan in Proliferating Cells
S. Evanko (1999)
10.1016/j.colsurfa.2004.06.030
Supramolecular structures prevailing in aqueous hyaluronic acid and phospholipid vesicles mixtures: an electron microscopy and rheometric study
Vittorio Crescenzi (2004)
10.1006/JSBI.1997.3908
Hyaluronan-phospholipid interactions.
I. Pasquali-Ronchetti (1997)
10.1016/J.JCIS.2007.09.070
The effect of added liposomes on the rheological properties of a hydrogel: a systematic study.
S. Mourtas (2008)
10.1167/IOVS.06-0783
LYVE-1-positive macrophages are present in normal murine eyes.
H. Xu (2007)
10.1167/IOVS.06-1305
Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes.
Laure Lajavardi (2007)



This paper is referenced by
10.1007/978-3-319-29346-2_18
Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye
V. Pillay (2016)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
10.1016/j.ejpb.2012.12.010
Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
A. Sabzevari (2013)
10.1016/j.jconrel.2016.02.013
Hyaluronic acid liposomal gel sustains delivery of a corticoid to the inner ear.
Naila El Kechai (2016)
10.1007/978-3-319-29346-2
Nano-Biomaterials For Ophthalmic Drug Delivery
Y. Pathak (2016)
10.1201/B12950-12
Drug Delivery to the Vitreous Humor
F. Béhar-Cohen (2012)
10.1002/jbm.a.34976
Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications.
L. K. Widjaja (2014)
10.1080/17425247.2019.1553953
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
Whitney Shatz (2018)
10.1016/j.ijpharm.2019.118987
Novel Liposome Aggregate Platform (LAP) system for sustained retention of drugs in the posterior ocular segment following intravitreal injection.
S. Blazaki (2019)
Sustained Release Intraocular Drug Delivery Devices for Treatment of Uveitis
N. Haghjou (2011)
10.1007/978-3-319-95807-1_24
Ocular Delivery of Peptides and Proteins
R. Dahiya (2018)
10.1080/17425247.2016.1227783
Recent perspectives on the delivery of biologics to back of the eye
M. Joseph (2017)
10.1007/s00405-016-4331-8
Effect of a liposomal hyaluronic acid gel loaded with dexamethasone in a guinea pig model after manual or motorized cochlear implantation
E. Mamelle (2016)
10.1016/j.ijpharm.2012.06.052
Proteins, polysaccharides, and their complexes used as stabilizers for emulsions: alternatives to synthetic surfactants in the pharmaceutical field?
Eléonore Bouyer (2012)
Gels d'acide hyaluronique contenant des liposomes pour la libération prolongée d'un corticoïde dans l'oreille interne
Naila El Kechai (2015)
10.1155/2011/396068
Preparation and Characterization of Stealth Archaeosomes Based on a Synthetic PEGylated Archaeal Tetraether Lipid
Julie Barbeau (2011)
10.1016/j.ejps.2017.08.028
Sustained release of intravitreal flurbiprofen from a novel drug‐in‐liposome‐in‐hydrogel formulation☆
K. Pachis (2017)
10.1002/adhm.202000731
Mastering the Tools: Natural versus Artificial Vesicles in Nanomedicine.
L. Leggio (2020)
10.1016/bs.apcsb.2014.11.006
Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.
R. Klippstein (2015)
10.1201/B14802-12
Nanoparticles for Ocular Drug Delivery
J. Barar (2013)
10.1089/jop.2011.0200
Safety evaluation of intracameral and subconjunctival injection of a novel mucoadhesive polysaccharide isolated from Bletilla striata in rabbit eye.
Xianggen Wu (2012)
10.1016/B978-0-12-384935-9.10005-7
Ocular Delivery of Peptides and Proteins
S. P. Vyas (2011)
10.1016/j.ejpb.2011.01.019
Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage.
K. Hironaka (2011)
10.1080/17425247.2016.1227785
Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications
Jennifer J. Kang-Mieler (2017)
10.1016/j.ijpharm.2017.03.029
Mixtures of hyaluronic acid and liposomes for drug delivery: Phase behavior, microstructure and mobility of liposomes.
Naila El Kechai (2017)
10.1089/JOP.2015.0047
Recent Advances in Topical Ocular Drug Delivery.
Y. Kashyap (2016)
10.1111/aos.12167
Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study
J. S. López-García (2014)
10.1016/B978-0-323-47347-7.00012-4
Relevant Aspects on Peptide Delivery from Nanostructured Therapeutic Systems
Marcos Luciano Bruschi (2016)
10.1016/S1773-2247(13)50016-5
Nano and microtechnologies for ophthalmic administration, an overview
R. Herrero-Vanrell (2013)
10.1039/c5bm00481k
Biodegradable liposome-encapsulated hydrogels for biomedical applications: a marriage of convenience.
S. Grijalvo (2016)
10.32657/10356/65222
Studies on the release behavior of drugs in hyaluronic acid-nano/micro carrier composite hydrogels
Bora Meghali (2015)
10.1517/13543784.2016.1128893
Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development
Raquel Salazar-Méndez (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar